Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
D001254:Astrocytoma / Q000532:radiotherapy; D001932:Brain Neoplasms / Q000378:metabolism* / Q000532:radiotherapy*; D001973:Bromodeoxyuridine / Q000378:metabolism* / Q000627:therapeutic use*; D046508:Culture Techniques; D004247:DNA / Q000378:metabolism; D005467:Floxuridine / Q000494:pharmacology; D005472:Fluorouracil / Q000494:pharmacology; D005500:Follow-Up Studies; D005910:Glioma / Q000532:radiotherapy; D006801:Humans; D008579:Meningioma / Q000532:radiotherapy; D008727:Methotrexate / Q000494:pharmacology; D009837:Oligodendroglioma / Q000532:radiotherapy; D011838:Radiation-Sensitizing Agents / Q000378:metabolism* / Q000627:therapeutic use*; D013936:Thymidine / Q000037:antagonists & inhibitors
D011838:Radiation-Sensitizing Agents; D005467:Floxuridine; D004247:DNA; D001973:Bromodeoxyuridine; D005472:Fluorouracil; D013936:Thymidine; D008727:Methotrexate